DENVER – The use of nintedanib 150 mg twice daily has been shown to slow disease progression in patients with idiopathic pulmonary fibrosis up to 76... More »
Achieving a cure in hepatitis C infection could result in significant economic gains, with a study estimating that the beneficial effects in terms of ... More »
WASHINGTON – The course of Crohn’s disease has changed for the better since the introduction of biological therapies and other treatments in the l... More »
WASHINGTON – A prescription for a statin was associated with about a 40% lower risk of new-onset inflammatory bowel disease in a study that evaluate... More »
SEATTLE – Heavier individuals are more likely to have degenerative changes of the lumbar spine seen on MRI, according to findings from an analysis o... More »
SILVER SPRING, MD. – A Food and Drug Administration advisory panel unanimously agreed that duodenoscopes that are properly cleaned and disinfected b... More »
SEATTLE – Hydroxychloroquine is not efficacious for treating primary hand osteoarthritis, according to results from the first randomized trial to te... More »
SEATTLE – Hydroxychloroquine is not efficacious for treating primary hand osteoarthritis, according to results from the first randomized trial to te... More »